| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $11,538,381 ) |
| | 2026 | 2026 | HEALTHPARTNERS INSTITUTE | 8170 33RD AVE S | MINNEAPOLIS | MN | 55425 | HENNEPIN | USA | R01CA283332 | Randomized Trial to Improve Care of Patients with Hereditary Cancer Syndromes | 000 | 3 | NIH | 7/1/2026 | $648,180 |
| | 2026 | 2026 | HEALTHPARTNERS INSTITUTE | 8170 33RD AVE S | MINNEAPOLIS | MN | 55425 | HENNEPIN | USA | R01DK145690 | Real-time Insights for Smart Engagement with CGM (RISE-CGM) | 000 | 1 | NIH | 7/16/2026 | $314,000 |
| | 2026 | 2026 | HEALTHPARTNERS INSTITUTE | 8170 33RD AVE S | MINNEAPOLIS | MN | 55425 | HENNEPIN | USA | R01AG100027 | An Optimization Trial of a Meaning and Theory-Based Digital Intervention to Increase Physical Activity (MAP to Health) | 001 | 1 | NIH | 8/14/2026 | $118,585 |
| | 2026 | 2026 | HEALTHPARTNERS INSTITUTE | 8170 33RD AVE S | MINNEAPOLIS | MN | 55425 | HENNEPIN | USA | R01AG100027 | An Optimization Trial of a Meaning and Theory-Based Digital Intervention to Increase Physical Activity (MAP to Health) | 000 | 1 | NIH | 6/30/2026 | $685,327 |
| | 2026 | 2026 | HEALTHPARTNERS INSTITUTE | 8170 33RD AVE S | MINNEAPOLIS | MN | 55425 | HENNEPIN | USA | R01NR022258 | An Artificial Intelligence Approach to Understanding Trade-offs in Emergency Department Decision-making | 000 | 1 | NIH | 7/27/2026 | $3,030,895 |
| | 2026 | 2026 | HEALTHPARTNERS INSTITUTE | 8170 33RD AVE S | MINNEAPOLIS | MN | 55425 | HENNEPIN | USA | U01DK143379 | Mitigating Diabetic Ketoacidosis in People with T1D and Chronic Kidney Disease on an SGLT1&2 Inhibitor: Ketosis Risk Factor Determination and Incorporation into an Enhanced Glucose Ketone Report | 001 | 1 | NIH | 9/17/2026 | $147,904 |
| | 2026 | 2026 | HEALTHPARTNERS INSTITUTE | 8170 33RD AVE S | MINNEAPOLIS | MN | 55425 | HENNEPIN | USA | K23MH142738 | Data-driven Development of Clinically Translatable EHR-Based Models to Estimate Severe Mood Episode Risk for Young People with Bipolar Disorder | 000 | 1 | NIH | 4/9/2026 | $199,747 |
| | 2026 | 2026 | HEALTHPARTNERS INSTITUTE | 8170 33RD AVE S | MINNEAPOLIS | MN | 55425 | HENNEPIN | USA | U01DK143379 | Mitigating Diabetic Ketoacidosis in People with T1D and Chronic Kidney Disease on an SGLT1&2 Inhibitor: Ketosis Risk Factor Determination and Incorporation into an Enhanced Glucose Ketone Report | 001 | 1 | NIH | 9/17/2026 | $1,394,924 |
| | 2026 | 2026 | HEALTHPARTNERS INSTITUTE | 8170 33RD AVE S | MINNEAPOLIS | MN | 55425 | HENNEPIN | USA | R01HD115580 | Neonatal, Lactation, and Child Health Outcomes Following RSV Vaccination During Pregnancy | 000 | 3 | NIH | 5/1/2026 | $673,986 |
| | 2026 | 2026 | HEALTHPARTNERS INSTITUTE | 8170 33RD AVE S | MINNEAPOLIS | MN | 55425 | HENNEPIN | USA | R01CA263542 | The Interplay of ENDS and Tobacco Control Policy: Impact on the Population Harms of Tobacco | 000 | 5 | NIH | 6/30/2026 | $345,636 |
| | 2026 | 2026 | HEALTHPARTNERS INSTITUTE | 8170 33RD AVE S | MINNEAPOLIS | MN | 55425 | HENNEPIN | USA | UG1CA189863 | Metro-Minnesota Community Oncology Research Consortium (MMCORC) | 002 | 13 | NIH | 9/11/2026 | $3,762,172 |
| | 2026 | 2026 | HEALTHPARTNERS INSTITUTE | 8170 33RD AVE S | MINNEAPOLIS | MN | 55425 | HENNEPIN | USA | K22DE032046 | Exploring Mechanisms of Hepatitis C Virus-Associated Xerostomia | 002 | 4 | NIH | 6/23/2026 | $232,172 |
| | 2026 | 2025 | HEALTHPARTNERS INSTITUTE | 8170 33RD AVE S | MINNEAPOLIS | MN | 55425 | HENNEPIN | USA | R01DK128281 | Reducing Clinical Inertia in Obesity Management of Diabetes in Primary Care: Cluster-Randomized Trial | 000 | 5 | NIH | 3/17/2026 | $0 |
| | 2026 | 2025 | HEALTHPARTNERS INSTITUTE | 8170 33RD AVE S | MINNEAPOLIS | MN | 55425 | HENNEPIN | USA | R01HD100579 | Treatment Initiation for New Episodes of Depression in Pregnant Women | 000 | 5 | NIH | 1/21/2026 | $0 |
| | 2026 | 2025 | HEALTHPARTNERS INSTITUTE | 8170 33RD AVE S | MINNEAPOLIS | MN | 55425 | HENNEPIN | USA | UG1CA189863 | Metro-Minnesota Community Oncology Research Consortium (MMCORC) | 001 | 12 | NIH | 2/6/2026 | $0 |
| | 2026 | 2025 | HEALTHPARTNERS INSTITUTE | 8170 33RD AVE S | MINNEAPOLIS | MN | 55425 | HENNEPIN | USA | K22DE032046 | Exploring Mechanisms of Hepatitis C Virus-Associated Xerostomia | 001 | 3 | NIH | 5/29/2026 | $0 |
| | 2026 | 2025 | HEALTHPARTNERS INSTITUTE | 8170 33RD AVE S | MINNEAPOLIS | MN | 55425 | HENNEPIN | USA | U01DK143379 | Mitigating Diabetic Ketoacidosis in People with T1D and Chronic Kidney Disease on an SGLT1&2 Inhibitor: Ketosis Risk Factor Determination and Incorporation into an Enhanced Glucose Ketone Report | 000 | 1 | NIH | 1/26/2026 | -$14,986 |
| | 2026 | 2024 | HEALTHPARTNERS INSTITUTE | 8170 33RD AVE S | MINNEAPOLIS | MN | 55425 | HENNEPIN | USA | UG1CA189863 | Metro-Minnesota Community Oncology Research Consortium (MMCORC) | 000 | 12 | NIH | 2/6/2026 | $0 |
| | 2026 | 2024 | HEALTHPARTNERS INSTITUTE | 8170 33RD AVE S | MINNEAPOLIS | MN | 55425 | HENNEPIN | USA | K22DE032046 | Exploring Mechanisms of Hepatitis C Virus-Associated Xerostomia | 000 | 2 | NIH | 5/29/2026 | $0 |
| | 2026 | 2024 | HEALTHPARTNERS INSTITUTE | 8170 33RD AVE S | MINNEAPOLIS | MN | 55425 | HENNEPIN | USA | R01HD107753 | Maternal COVID-19 Vaccination and Lactation Outcomes | 000 | 3 | NIH | 8/24/2026 | -$161 |
|
| Issue Date FY: 2025 ( Subtotal = $9,832,955 ) |
| | 2025 | 2025 | HEALTHPARTNERS INSTITUTE | 8170 33RD AVE S | MINNEAPOLIS | MN | 55425-4516 | HENNEPIN | USA | R01HD100579 | Treatment Initiation for New Episodes of Depression in Pregnant Women | 000 | 5 | NIH | 4/3/2025 | $547,471 |
| | 2025 | 2025 | HEALTHPARTNERS INSTITUTE | 8170 33RD AVE S | MINNEAPOLIS | MN | 55425-4516 | HENNEPIN | USA | UH3DE030063 | Investigating Behavioral Mechanisms and Efficacy of a Provider-Directed Intervention for HPV Vaccine Promotion in Real-World Dental Settings | 000 | 3 | NIH | 3/5/2025 | $757,577 |
| | 2025 | 2025 | HEALTHPARTNERS INSTITUTE | 8170 33RD AVE S | MINNEAPOLIS | MN | 55425-4516 | HENNEPIN | USA | UH3DE030063 | Investigating Behavioral Mechanisms and Efficacy of a Provider-Directed Intervention for HPV Vaccine Promotion in Real-World Dental Settings | 001 | 3 | NIH | 3/12/2025 | $0 |
| | 2025 | 2025 | HEALTHPARTNERS INSTITUTE | 8170 33RD AVE S | MINNEAPOLIS | MN | 55425-4516 | HENNEPIN | USA | R01DK128281 | Reducing Clinical Inertia in Obesity Management of Diabetes in Primary Care: Cluster-Randomized Trial | 000 | 5 | NIH | 6/3/2025 | $630,033 |
| | 2025 | 2025 | HEALTHPARTNERS INSTITUTE | 8170 33RD AVE S | MINNEAPOLIS | MN | 55425 | HENNEPIN | USA | UG1CA189863 | Metro-Minnesota Community Oncology Research Consortium (MMCORC) | 001 | 12 | NIH | 8/11/2025 | $4,075,539 |
| | 2025 | 2025 | HEALTHPARTNERS INSTITUTE | 8170 33RD AVE S | MINNEAPOLIS | MN | 55425 | HENNEPIN | USA | UH3DE030063 | Investigating Behavioral Mechanisms and Efficacy of a Provider-Directed Intervention for HPV Vaccine Promotion in Real-World Dental Settings | 002 | 3 | NIH | 7/3/2025 | -$684,562 |
| | 2025 | 2025 | HEALTHPARTNERS INSTITUTE | 8170 33RD AVE S | MINNEAPOLIS | MN | 55425-4516 | HENNEPIN | USA | R01CA283332 | Randomized Trial to Improve Care of Patients with Hereditary Cancer Syndromes | 001 | 2 | NIH | 5/28/2025 | $65,646 |
| | 2025 | 2025 | HEALTHPARTNERS INSTITUTE | 8170 33RD AVE S | MINNEAPOLIS | MN | 55425-4516 | HENNEPIN | USA | R01CA283332 | Randomized Trial to Improve Care of Patients with Hereditary Cancer Syndromes | 000 | 2 | NIH | 3/3/2025 | $590,800 |
| | 2025 | 2025 | HEALTHPARTNERS INSTITUTE | 8170 33RD AVE S | MINNEAPOLIS | MN | 55425 | HENNEPIN | USA | U01DK143379 | Mitigating Diabetic Ketoacidosis in People with T1D and Chronic Kidney Disease on an SGLT1&2 Inhibitor: Ketosis Risk Factor Determination and Incorporation into an Enhanced Glucose Ketone Report | 000 | 1 | NIH | 8/22/2025 | $2,367,892 |
| | 2025 | 2025 | HEALTHPARTNERS INSTITUTE | 8170 33RD AVE S | MINNEAPOLIS | MN | 55425-4516 | HENNEPIN | USA | R01HD115580 | Neonatal, Lactation, and Child Health Outcomes Following RSV Vaccination During Pregnancy | 000 | 2 | NIH | 4/3/2025 | $681,509 |
| | 2025 | 2025 | HEALTHPARTNERS INSTITUTE | 8170 33RD AVE S | MINNEAPOLIS | MN | 55425-4516 | HENNEPIN | USA | R01CA263542 | The Interplay of ENDS and Tobacco Control Policy: Impact on the Population Harms of Tobacco | 000 | 4 | NIH | 6/30/2025 | $562,207 |
| | 2025 | 2025 | HEALTHPARTNERS INSTITUTE | 8170 33RD AVE S | MINNEAPOLIS | MN | 55425-4516 | HENNEPIN | USA | K22DE032046 | Exploring Mechanisms of Hepatitis C Virus-Associated Xerostomia | 000 | 3 | NIH | 6/3/2025 | $242,972 |
| | 2025 | 2024 | HEALTHPARTNERS INSTITUTE | 8170 33RD AVE S | MINNEAPOLIS | MN | 55425 | HENNEPIN | USA | UG3DE030063 | Investigating Behavioral Mechanisms and Efficacy of a Provider-Directed Intervention for HPV Vaccine Promotion in Real-World Dental Settings | 001 | 2 | NIH | 7/3/2025 | -$2,820 |
| | 2025 | 2024 | HEALTHPARTNERS INSTITUTE | 8170 33RD AVE S | MINNEAPOLIS | MN | 55425-4516 | HENNEPIN | USA | UG3DE030063 | Investigating Behavioral Mechanisms and Efficacy of a Provider-Directed Intervention for HPV Vaccine Promotion in Real-World Dental Settings | 000 | 2 | NIH | 3/4/2025 | $0 |
| | 2025 | 2024 | HEALTHPARTNERS INSTITUTE | 8170 33RD AVE S | MINNEAPOLIS | MN | 55425 | HENNEPIN | USA | UG1CA189863 | Metro-Minnesota Community Oncology Research Consortium (MMCORC) | 000 | 12 | NIH | 8/8/2025 | $0 |
| | 2025 | 2024 | HEALTHPARTNERS INSTITUTE | 8170 33RD AVE S | MINNEAPOLIS | MN | 55425 | HENNEPIN | USA | R33AG069770 | A Technology-Driven Intervention to Improve Early Detection and Management of Cognitive Impairment | 001 | 5 | NIH | 8/28/2025 | $0 |
| | 2025 | 2024 | HEALTHPARTNERS INSTITUTE | 8170 33RD AVE S | MINNEAPOLIS | MN | 55425 | HENNEPIN | USA | R33AG069770 | A Technology-Driven Intervention to Improve Early Detection and Management of Cognitive Impairment | 000 | 5 | NIH | 8/13/2025 | $0 |
| | 2025 | 2024 | HEALTHPARTNERS INSTITUTE | 8170 33RD AVE S | MINNEAPOLIS | MN | 55425-4516 | HENNEPIN | USA | R01HD107753 | Maternal COVID-19 Vaccination and Lactation Outcomes | 004 | 3 | NIH | 7/29/2025 | $0 |
| | 2025 | 2024 | HEALTHPARTNERS INSTITUTE | 8170 33RD AVE S | MINNEAPOLIS | MN | 55425-4516 | HENNEPIN | USA | R01HD107753 | Maternal COVID-19 Vaccination and Lactation Outcomes | 003 | 3 | NIH | 7/11/2025 | $0 |
| | 2025 | 2024 | HEALTHPARTNERS INSTITUTE | 8170 33RD AVE S | MINNEAPOLIS | MN | 55425-4516 | HENNEPIN | USA | R01HD107753 | Maternal COVID-19 Vaccination and Lactation Outcomes | 000 | 3 | NIH | 3/13/2025 | $0 |
| | 2025 | 2023 | HEALTHPARTNERS INSTITUTE | 8170 33RD AVE S | MINNEAPOLIS | MN | 55425 | HENNEPIN | USA | R01HD107753 | Maternal COVID-19 Vaccination and Lactation Outcomes | 005 | 2 | NIH | 8/15/2025 | $0 |
| | 2025 | 2023 | HEALTHPARTNERS INSTITUTE | 8170 33RD AVE S | MINNEAPOLIS | MN | 55425-4516 | HENNEPIN | USA | R01HD107753 | Maternal COVID-19 Vaccination and Lactation Outcomes | 002 | 2 | NIH | 7/11/2025 | $0 |
| | 2025 | 2023 | HEALTHPARTNERS INSTITUTE | 8170 33RD AVE S | MINNEAPOLIS | MN | 55425-4516 | HENNEPIN | USA | R01HD107753 | Maternal COVID-19 Vaccination and Lactation Outcomes | 001 | 2 | NIH | 3/20/2025 | $0 |
| | 2025 | 2022 | HEALTHPARTNERS INSTITUTE | 8170 33RD AVE S | MINNEAPOLIS | MN | 55425 | HENNEPIN | USA | R01HL136937 | A Team-Based and Technology Driven Adherence Intervention to Improve Chronic Disease Outcomes | 000 | 5 | NIH | 6/13/2025 | -$117 |
| | 2025 | 2022 | HEALTHPARTNERS INSTITUTE | 8170 33RD AVE S | MINNEAPOLIS | MN | 55425 | HENNEPIN | USA | R21AG070161 | Development and Proof-of-Concept Trial of a Meaning and Theory-Based Physical Activity Intervention | 000 | 2 | NIH | 10/15/2024 | -$9 |
| | 2025 | 2021 | HEALTHPARTNERS INSTITUTE | 8170 33RD AVE S | MINNEAPOLIS | MN | 55425 | HENNEPIN | USA | R01AG052533 | Hotspotting Cardiometabolic Disparities for Simulated Advances in Population Care | 000 | 4 | NIH | 1/3/2025 | -$1,184 |
| | 2025 | 2021 | HEALTHPARTNERS INSTITUTE | 8170 33RD AVE S | MINNEAPOLIS | MN | 55425 | HENNEPIN | USA | R21AG074368 | Factors Associated with Healthcare Utilization Among Community-Dwelling Adults with Clinical Features of Dementia with Lewy Bodies | 000 | 1 | NIH | 1/6/2025 | $0 |
|
| Issue Date FY: 2024 ( Subtotal = $10,599,498 ) (Continued on the next page) |
|
